Celanese Corp. 2006 Annual Report (10-K) Summary
Business Context and Reporting Period
This Form 10-K covers the fiscal year ended December 31, 2006. Celanese Corporation is an integrated global hybrid producer of value-added industrial chemicals. The company operates through four primary segments: Chemical Products (acetyl products, solvents), Technical Polymers Ticona (engineering plastics), Acetate Products (cigarette filters), and Performance Products (food ingredients). The reporting period reflects the "Successor" entity following the acquisition of Celanese AG (CAG) in 2004. As of December 31, 2006, Celanese owned approximately 98% of CAG, with the remaining 2% acquired in January 2007 via a "Squeeze-Out."
Key Financial Metrics (Year Ended Dec 31, 2006)
| Metric | 2006 Value | 2005 Value |
|---|---|---|
| Net Sales | $6,656 million | $6,033 million |
| Operating Profit | $747 million | $573 million |
| Net Earnings | $406 million | $277 million |
| Diluted EPS (Continuing Ops) | $2.37 | $1.66 |
| Operating Cash Flow | $751 million | $701 million |
| Total Debt | $3,498 million | $3,437 million |
| Cash and Equivalents | $791 million | $390 million |
| Net Debt | $2,707 million | $3,047 million |
| Capital Expenditures | $252 million | $212 million |
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 10.3% to $6.656 billion, driven by a 4% price increase (due to strong demand and higher raw material costs) and a 1% volume increase. The full-year contribution from the Acetex acquisition (acquired July 2005) added $542 million in sales.
- Profitability: Operating profit rose 30.3% to $747 million. This was driven by higher volumes/pricing, productivity improvements, and a significant reduction in "Other (charges) gains, net" (which improved from a $66 million charge in 2005 to a $10 million charge in 2006). The 2005 period included one-time charges for asset impairments and restructuring not present in 2006.
- Interest Expense: Interest expense decreased to $294 million from $387 million in 2005, primarily due to the absence of $74 million in early redemption premiums and $28 million in accelerated amortization of deferred financing costs recorded in 2005.
- Segment Performance:
- Chemical Products: Sales up 10% to $4.742 billion; Operating profit up 9% to $637 million.
- Ticona: Sales up 3% to $915 million; Operating profit surged 142% to $145 million, aided by the exit of the loss-making COC business in 2005.
- Acetate Products: Sales up 6% to $700 million; Operating profit up 58% to $106 million.
- Performance Products: Sales declined 2% to $176 million due to lower pricing on Sunett sweetener, though volumes increased 7%.
Guidance, Outlook, and Risks
- Divestitures and Acquisitions: In December 2006, Celanese signed an agreement to sell its oxo products and derivatives businesses (including European Oxo GmbH) to Advent International for €480 million, expected to close in Q1 2007. The company also agreed to acquire Acetate Products Limited (UK) for approximately £57 million, closing in January 2007.
- Capital Projects: A 600,000 metric ton acetic acid plant in Nanjing, China, is scheduled for commercial sales in 2007. Capital expenditures for 2007 are expected to be approximately $280 million.
- Frankfurt Airport Settlement: The company reached a settlement with Fraport regarding the relocation of its Kelsterbach, Germany plant. Fraport will pay €650 million over five years to offset transition costs.
- Key Risks:
- Debt Levels: Total debt is approximately $3.5 billion. The company is highly leveraged, which limits flexibility and increases vulnerability to economic downturns.
- Raw Material Volatility: Significant exposure to natural gas, ethylene, and energy prices. The company uses hedging but cannot guarantee full pass-through of costs to customers.
- Legal and Environmental: Ongoing litigation regarding plumbing actions and sorbates antitrust matters (reserves of $214 million). Environmental remediation obligations remain significant.
- Currency: Significant operations in Europe expose the company to exchange rate fluctuations, particularly the Euro vs. USD.
Investor Verification Checklist
- Debt Covenants: Verify compliance with financial covenants in the senior credit facilities (leverage ratio, interest coverage) given the high debt load.
- Divestiture Closing: Confirm the closing of the Oxo products sale to Advent International and the final purchase price adjustments.
- China Expansion: Monitor the startup timeline and cost overruns for the Nanjing acetic acid plant.
- Legal Reserves: Review updates on the plumbing and sorbates litigation reserves ($214 million) and potential insurance recoveries.
- Raw Material Costs: Assess the ability to pass through rising natural gas and energy costs to customers in the Chemical Products segment.
- Frankfurt Relocation: Track the progress and cost neutrality of the Kelsterbach plant relocation settlement.